Dicot Pharma AB (FRA:KN0)

Market Cap	67.08M -59.1%
Revenue (ttm)	n/a
Net Income	-5.98M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0133
Previous Close	0.0133
Day's Range	0.0133 - 0.0133
52-Week Range	0.0101 - 0.1100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 23, 2026

About Dicot Pharma AB

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It develops LIB-01 that is in Phase 2a clinical trial for the treatment of erectile dysfunction and under medical discovery for treating premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden.

• Industry: Pharmaceutical Preparations
• Founded: 2015
• Employees: 4
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: KN0

Financial Performance

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error